Status
Conditions
Treatments
About
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy.
Participant Population/Primary Condition: Patients admitted to Intensive Care
Main Questions Aims to Answer:
Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons.
At the two-year follow-up, the health-related quality of life will be assessed
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
300 participants in 1 patient group
Loading...
Central trial contact
Lorenzo Gamberini, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal